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Abstract
Background: The increasing number of developmental events and molecular mechanisms associated with the
Hedgehog (Hh) pathway from Drosophila to vertebrates, suggest that gene regulation is crucial for diverse cellular
responses, including target genes not yet described. Although several high-throughput, genome-wide approaches
have yielded information at the genomic, transcriptional and proteomic levels, the specificity of Gli binding sites
related to direct target gene activation still remain elusive. This study aims to identify novel putative targets of Gli
transcription factors through a protein-DNA binding assay using yeast, and validating a subset of targets both in-
vitro and in-vivo. Testing in different Hh/Gli gain- and loss-of-function scenarios we here identified known (e.g.,
ptc1) and novel Hh-regulated genes in zebrafish embryos.
Results: The combined yeast-based screening and MEME/MAST analysis were able to predict Gli transcription
factor binding sites, and position mapping of these sequences upstream or in the first intron of promoters served
to identify new putative target genes of Gli regulation. These candidates were validated by qPCR in combination
with either the pharmacological Hh/Gli antagonist cyc or the agonist pur in Hh-responsive C3H10T1/2 cells. We
also used small-hairpin RNAs against Gli proteins to evaluate targets and confirm specific Gli regulation their
expression. Taking advantage of mutants that have been identified affecting different components of the Hh/Gli
signaling system in the zebrafish model, we further analyzed specific novel candidates. Studying Hh function with
pharmacological inhibition or activation complemented these genetic loss-of-function approaches. We provide
evidence that in zebrafish embryos, Hh signaling regulates sfrp2, neo1, and c-myc expression in-vivo.
Conclusion: A recently described yeast-based screening allowed us to identify new Hh/Gli target genes,
functionally important in different contexts of vertebrate embryonic development.
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Background
The Sonic hedgehog (Shh)/Gli pathway orchestrates sev-
e r a lp r o c e s s e ss u c ha sc e l lp r o l i feration, differentiation,
and stem cell maintenance [1]. Shh acts as a secreted
protein ligand that binds to the 12-transmembrane
receptor Ptc1 (Patched/Ptch/Ptch1). This binding
releases Ptc1 repression of the 7-transmembrane co-
receptor Smoothened, which in turn favours intracellu-
lar accumulation of activator forms of the Gli transcrip-
tion factors (Gli-A). In vertebrates, at least three Gli
proteins (Gli1, Gli2 and Gli3) have been described.
These zinc-finger transcription factors enter the nucleus
and bind specific sequences (GACCACCCA) in the gen-
ome known as Gli Binding sites (GBS), promoting
expression of target genes, including ptc1 and gli1 them-
selves [2]. In the absence of ligand, Ptc1 represses
Smoothened activity and the repressor forms of the
transcription factors Gli (Gli-R) enter the nucleus and
inhibit Hh target gene transcription. The relative ratio
of Gli-A/Gli-R forms is considered to be crucial for
interpreting the extracellular Hh gradient and for deter-
mining concentration-dependent cell fates [3,4]. Due the
multiple developmental and growth processes where the
Hh/Gli pathway has been implicated, it is likely that the
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To date, based on the identification of a Gli binding
motif within their regulatory sequences, no more than a
dozen target genes have been characterized to be acti-
vated or inhibited by Gli activity in vertebrates. Several
in silico and experimental genomic analyses, such as
ChIP-seq and ChIP-Chip, have been recently made to
identify new gene direct targets, mainly identifying puta-
tive GBS near the transcriptional start site of genes
[5-8]. However, it has been shown that different geno-
mic strategies yield different hedgehog target lists.
In order to contribute to the identification of new
GBS we applied a recently described yeast-based screen
[9] using mouse and zebrafish genomic libraries. This
versatile yeast strategy allowed us to rapidly and effi-
ciently identify genomic targets of Gli-binding proteins.
Bioinformatic analyses (MEME/MAST) were performed
to determine the presence of enriched elements
upstream or in the first intron of putative targets identi-
fied by our one-hybrid assay. Using this heterologous
a p p r o a c h ,w ew e r ea b l et oi d e n t i f ys e v e r a ln o v e lG l i -
binding sequences located close to genes previously not
connected to the Shh/Gli pathway. Due to the high con-
servation of the Hh/Gli pathway in vertebrates, some of
the identified putative targets were further analyzed,
both in-vitro using a mouse Hh reporter fibroblast cell
line, and in-vivo in zebrafish embryos, confirming their
predicted regulation through Hh loss and gain-of-func-
tion experiments. The high rate of identified target
genes supports our unbiased approach and shows the
potency of this method for finding novel target genes.
Results
Yeast-based screens identify Gli protein-binding
sequences
In order to identify possible GBS, we used our recently
described yeast-based assay that uses mouse and zebra-
fish libraries with random genomic fragments upstream
of the yeast URA3 promoter [9]. The zebrafish library
had an average genomic fragment size of 300 bp, and
contains approximately 3 × 10
7 independent clones pro-
viding a 4- to 6-fold coverage of the genome, while the
mouse library contains 1.7 × 10
7 independent clones
with an average size of 700 bp, representing an average
of 3- to 4-fold coverage of the genome. MATa yeast
containing the genome library fragment plasmids were
mated separately to MATa yeast containing an expres-
sion plasmid for either the full-length zebrafish Gli1 or
the zinc-finger domain of the mouse Gli2 protein, fol-
lowing a standard two-hybrid mating protocol, screening
afterwards a total of 611 clones [10]. Clones were then
re-screened for a URA3 phenotype and the genomic
fragment was PCR amplified using primers flanking the
genomic library. Sequencing a total of 512 single
product colony-PCR reactions, we successfully obtained
235 potential binding sequences for the mouse library,
and 197 for the zebrafish library.
MEME and MAST analysis predict multiple Shh/Gli target
genes
The consensus GBS, GACCACCCA, was first described
by the Vogelstein group [11]. Several other genes that
have been reported as targets of Gli1 in different biolo-
gical processes, posses motifs with distinct degrees of
similarity to the consensus sequences in their upstream
regions. These motifs were able to bind a recombinant
form of Gli1 in gel-shift assays [12]. From the 432
sequences obtained from the yeast assay, we manually
curated them based on two criteria: first, we considered
those sequences mapping within 20 kb of the transcrip-
tional start of a gene or to the first intron, and second,
we ruled out sequences that have been described as
repetitive in multiple genome assemblies. We therefore
did not consider the intergenic repetitive sequences,
although they show tandem repeats that probably could
bind the Gli transcription factors. Nevertheless, for the
p u r p o s eo ft h i ss t u d y ,t h e yw e r ed i s c a r d e db a s e do nt h e
fact that they do not show the Gli consensus binding
sites or other known transcription factor binding sites.
Next, we selected for further analysis and logo genera-
tion the mouse sequences since they fulfilled our
request of mapping criteria. This yielded a list of 128,
mouse sequences, with final 66 non-redundant
sequences (Additional File 1), mapped to specific genes
based on shortest distance to the transcriptional start
site. These sequences were used as input for a MEME
search.
A ss h o w ni nF i g u r e1 A ,w eu s e dt h eM E M E[ 1 3 , 1 4 ]
algorithm to identify overrepresented motifs in the
group of 128 sequences (Additional File 1). A predicted
site, a 14 bp motif (Figure 1A), contained the core con-
sensus of GBS as described in [11]. The position-depen-
dent scoring matrix for the 14 bp motif was used as
input to the MAST algorithm to search similar motifs
in a 20 kb upstream region and in the first intron of 10
candidate genes, including ptc1, candidate genes were
selected based on gene ontology associations, to cover a
wide array of cellular and developmental processes (Fig-
u r e1 C ) .F i g u r e1 Bs h o w st h er e p r e s e n t a t i v el o g o so f
potential Gli-binding sites identified in the non-coding
regions of the selected genes, for each gene the number
of sequences that matched to the 14 bp motif is indi-
cated in the brackets right next to gene name.
We also checked the sequences for interspecies con-
servation, finding a high percentage for some of them in
a murine/human comparison (like neo1 and cdh13), par-
tial human/murine conservation for others (kif21a,
rps6ka3), some with murine-only conservation (like
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(sfrp2) (Additional File 2).
Putative Gli-targets genes display altered mRNA levels
after pharmacological blockage or activation of Hh/Gli
signaling pathway
Assessing whether regulatory elements are occupied in-
vivo requires experimental confirmation. In order to
address whether any of the putative 9 target genes are
affected by Hh pathway loss of function, we made use of
the reporter cell line C3H10T1/2 and assayed the candi-
date target genes for their response to Hh signaling by
quantitative RT-PCR (qPCR). Cells were cultured in the
presence of the Hh/Gli pathway inhibitor cyclopamine
(cyc) (10 μM) and three time points were considered (6,
12 and 24 hours) to account for differences in the tem-
poral transcriptional response of putative Gli-target
genes and for differences in the stability of mRNAs pro-
duced under Gli control. Vehicle control (EtOH) was
used as reference.
All the selected candidate genes showed reductions in
their mRNA levels after 24-hour cyc treatments except
glra (Figure 2). To corroborate Hh regulation we per-
formed gain of function experiments using purmorpha-
mine (pur), a proven Smoothened agonist [15] for a
subset of candidates, namely neo1, c-myc and sfrp2
based on their implication in developmental processes.
Cells were treated for 24 hours and 48 hours before
RNA extraction and qPCR processing. ptc1,aw e l l
known Hh transcriptional readout was used as positive
control. For both c-myc and neo1 significant changes
could be observed after 24-hours of treatment, neverthe-
less the increases was less pronounced in comparison to
ptc1. In order to proof that the effects of Hh signaling
were direct we included experiments with cycloheximide
(CHX), obtaining similar results (Additional File 3).
Increase in transcript levels of the selected target genes
became clearly evident after 48 hours of treatment.
Sfrp2 did not show any changes in expression for either
time point (Figure 3). sfrp2 invariant mRNA levels possi-
bly points to a context dependent case of regulation.
Expression changes were calculated related to vehicle
treatments (DMSO).
Based on the Gli-specific effect on transcription of novel
target genes obtained by the screening and further in-vitro
validation experiments for neo1, c-myc and sfrp2,w ea l s o
verified Hh regulation of these genes by whole mount in
situ hybridization (ISH) in zebrafish embryos. Besides
allowing a relatively rapid verification of gene expression
in different Hh-manipulated embryos, this approach pro-
vides spatial information and insights about the nature of
regulation by Hh signaling. Because the Shh/Gli pathway
plays a central role in neural development, particularly in
the development of the central nervous system (CNS), we
choose these known developmental genes not previously
reported to be regulated by Shh signaling.
Neogenin 1 is positively regulated by the Shh/Gli pathway
in in the CNS
Neogenin 1 is a multifunctional transmembrane recep-
tor belonging to the immunoglobulin superfamily with
known roles in angiogenesis, progenitor proliferation
and axon guidance [16]. At 48 hours post fertilization
(hpf) neo1 expression was strongly detected in the wild-
type CNS, where it was associated with proliferative
zones (optic tectum, eye and diencephalon, Figure 4A-
E). Of note, neo1 was also detected in the notochord
(Figure 4D, bracket). ISH analysis shows no staining in
the notochord and the retinal ganglion cell layer of the
eye in dtr (gli1) and smu (smo) mutants (Figure 4F-I,
bracket and arrowhead).
In addition to genetic loss-of-function, we comple-
mented our analysis by treating embryos with the Shh/
Gli activator pur. Of note, in particular notochord
expression is increased when compared to mock DMSO
treated embryos (Figure 4J, K, bracket).
c-myc is regulated by the Shh/Gli pathway in the CNS and
liver
We next asked whether c-myc (myca), a multifunctional
gene directly related to cell cycle progression (G1/S
Gene name Short name Associated funcƟons (AmiGO)
Secreted frizzled-related protein 2 sfrp2 Bone morphogenesis, chondrocyte development, BMP & Wnt-canonical antagonist
Cadherin-13 cdh13 Cell adhesion, cell migraƟon
Myelocytomatosis oncogene myc Cell cycle progression, cell proliferaƟon, 
Neogenin-1 neo1 Axon guidance, cell adhesion, BMP antagonist
Kinesin-like protein KIF21A kif2 Microtubule-based movement, ATP binding
Ribosomal protein S6 kinase alpha-1 rps6ka1 Protein phosphorylaƟon, Toll signaling pathway, axon guidance
Integrin alpha-1 itga1 Cell chemotaxis, cell adhesion, MAPK acƟvity, integrin signaling pathway
Ribosomal protein S6 kinase alpha-3 rps6ka3 Signal transducƟon, Toll signaling pathway, protein phosphorylaƟon
Glycine receptor subunit alpha-2 glra2 Ion membrane transport, cell juncƟon, glycine binding
AB
kif21a (1)
rps6ka1 (5)
cdh13 (62)
c-myc (9)
sfrp2 (2)
glra2 (5)
rps6ka3 (6)
neo1 (10)
ptc1 (8)
itga1 (11)
upstream 1st intron
One-hybrid
sequences
(n= 432)
Training group
(n=66)
MEME MAST
Bindingmotifs
(n=3)
Candidategenes
(n=10)
C
Figure 1 Motif search strategy. A) Diagram of the bioinformatic
workflow for sequence analysis. A subgroup of sequences from the
one-hybrid assay was used to search for motifs using MEME. Logos
on the right represent the position-dependent matrix based in the
alignment for GLI transcription factor candidate motifs. The matrix
was also used as input to the MAST algorithm to identify potential
Gli-binding sites in non-coding regions of candidate genes. B)
Motifs identified with MEME/MAST strategy. Logos represent the
alignment of the potential binding sites identified in each sequence
in both upstream (left column) and intronic (right column) for nine
candidate genes. Numbers of potential binding sites are indicated
in brackets next to gene name. C) Gene ontology table for selected
putative target genes found in (B).
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Figure 2 Expression analysis of Gli-target candidate genes in control and cyc treated-cells. Real-time RT-PCR analysis of expression of
genes control gene ptc1 (Patched1), cdh13 (cadherin 13), neo1 (Neogenin 1), sfrp2 (Secreted Frizzled Related Protein 2), rps6ka3 (ribosomal protein S6
kinase polypeptide 3), rps6ka1 (ribosomal protein S6 kinase polypeptide 1), c-myc (myelocytomatosis oncogene), kif2 (Kinesin Heavy Chain Member 2),
itga1 (integrin alpha 1) and glra2 (glycine receptor, alpha 2 subunit) in control cells and in cells treated with 10 μM cyc or control (vehicle EtOH)
for 6, 12 or 24 hours before harvesting. Data shown are transcript levels relative to housekeeping gene gapdh (glyceraldehyde 3-phospate
dehydrogenase). Values correspond to the mean and SE of at least triplicate determinations and asterisks indicate significant difference between
control and treated cells (ANOVA, p < 0.05). Black bars, control samples and white bars, inhibitor treated samples.
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lated by Shh [17]. At 48 hpf wild-type c-myc expression
is found in the posterior margin of the optic tectum,
recently identified as an important proliferative zone in
the dorsal brain of teleosts (Figure 5A, arrow) [18,19].
The mRNA can also be detected in the eye and liver
(Figure 5A asterisk). In the smu mutant, expression in
CNS and liver was completely diminished (Figure 5B).
dtr mutants did not show any c-myc staining; expression
is regionally lost in the dorsal midbrain, eye and liver
(Figure 5C, arrow indicates eye) whereas the yot (gli2)
mutant has a reduced expression in the eye while c-myc
was still detectable in the tectum and liver (Figure 5D).
Thus, ISH analysis corroborated the changes in c-myc
expression levels that were previously determined by
qPCR assays.
sfrp2 gene is regulated by the Shh pathway in slow
muscle and pharyngeal arches
The sfrp2 gene encodes a protein that binds Wnt
ligands through a cystein-rich domain (CRD). It has
been implicated in both antagonism of Wnt signaling
[20] and beta-catenin stabilization [21]. ISH analysis ver-
ified that sfrp2 transcripts can be detected in adaxial
cells, pectoral fins and branchial arches by the 48 hpf
stage, as previously reported [22]. Adaxial cell expres-
sion is absent in yot mutants, and expression is also
regionally lost in the CNS (Figure 6B, B’’’). Pectoral fins
do not display any changes in sfrp2 expression. This is
consistent with the reported alterations in myogenesis in
yot mutants, where slow muscle genesis is affected [23].
ptc 1
c-myc
sfrp2
neo1/gapdh
Figure 3 Pharmacological gain of function of the Shh/Gli
pathway activates transcription of novel target genes.A )
C3H10T1/2 cells were cultured for 48 h in 10 μM pur or its control
(vehicle DMSO) and processed for qPCR. c-myc shows significant
differences in mRNA levels, whereas sfrp2 does not. ptc 1 is shown
as a positive control. B) neo1 mRNA levels are increased after the
same 48 h treatment of C3H10T1/2 cells, graph showed separately
due to use of TaqMan probes.
Figure 4 neo1 expression is reduced in Shh/Gli pathway
mutants and increased on Shh/Gli pharmacological activation.
neo1 is expressed broadly in the developing CNS (A). Expression in
48 hpf embryo can be detected in the otic vesicle, in the
notochord (B, close-up D, black bracket) and in the eye (E, black
arrowhead), probably in the retinal ganglion cell layer (gcl). (C)
Cartoon of a 48 hpf zebrafish eye. Blue line shows neo1 expression
in the gcl. At 48 hpf neo1 expression is diminished in gli1 (dtr) and
smu (smo) mutants, specifically in the notochord (F, H, bracket) and
the gcl in the optic placode (G, I; black arrowhead) in comparison
to WT (D, E). (J, K) neo1 mRNA is increased in notochord. Note that
(J) and (K) controls were developed at different times in comparison
to (D) in order to match to their corresponding pur treatment (K).
Anterior is towards left, lateral views are showed except in (E, G, I, K)
with dorsal views anterior up. Scale bars; 50 μm except in A (100
μm). WT; wild type. gcl; retinal-ganglion cell layer. DMSO is the
vehicle for pur.
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opposes the Shh signaling gradient in the neural tube,
regulation of sfrp2 in the brain by Shh has not pre-
viously been demonstrated.
To further examine whether sfrp2 is regulated by Shh
we used pharmacological gain and loss of function
approaches. Sfrp2 expression is increased in pur treated
embryos in comparison to its vehicle treatment (Figure
6E). Although cyc inhibitor does not ablate completely
expression in the CNS, expression in the developing
pharyngeal arch is abolished. (Figure 6C, see asterisk).
This might be due to the fact that treatments were
started at 8 hpf, due to an extremely high mortality rate
in treatment initiated prior to that time. The failure to
detect sfrp2 regulation in the first reporter cell assay
demonstrates the necessity to test regulation in the
proper, in-vivo context.
Discussion
The Hedgehog pathway has been extensively studied.
Many studies take advantage of high throughput
approaches at different levels, for example by identifying
the post-translational modifiers mediating Hh signaling
[24], by mapping GBS and Gli responding genes in silico
[25] or in different cellular models [26]. In general, ChIP
assays utilize specific PCR primers flanking a suspected
binding site to determine whether the site is occupied.
Still, recent studies suggest that these regions, at least
for mammalian genomes, are more complex than pre-
viously imagined and therefore ChIP-on chip may miss
some regulatory regions. ChIP-Seq is another approach,
but like ChIP-on chip, it requires high quality antibodies
to the transcription factor of interest. The latter has
been a big handicap particularly in the HH/Gli field; the
development of ChIP grade of Gli antibodies is still a
matter of intense research. To improve the number of
target genes associated with the Shh/Gli pathway, we
performed a yeast-based genomic screening assay com-
bined with in silico analysis in order to characterize
novel Gli interacting sequences. Yeast-based method has
been successfully applied to identify transcription factor
target genes in [9].
Identifying new Hh targets using a yeast-based method
Our strategy shows that sequences obtained by the yeast
based method possess potential binding sites for Gli
transcription factor whose consensus matches the 9 bp
core previously described. This method has the advan-
tage that it allows transcription binding site identifica-
tion for GBS that potentially cannot be found using
other strategies. Of note, we found fragments that con-
tain putative GBS sequences slightly different from what
has been previously reported as consensus sequences
(Figure 1B). Variations of these GBS lead us to examine
whether a correlation existed between these changes
and DNA binding domains for Gli family members.
Zinc fingers 4 and 5, responsible for binding to the con-
sensus sequence [27], are highly conserved specifically
B
D C
cmyc A
WT
4
8
 
h
p
f *
*
*
Figure 5 C-myc expression is lost in the CNS in Shh/Gli
pathway mutants.A )c-myc is normally expressed in the optic
tectum (black arrowhead) and the developing eye. Strong
expression is also detected in the liver (white asterisk). B) smu
mutant embryos show no expression of c-myc in the CNS. C) dtr
embryos have no c-myc in the eye (black arrow), tectum and liver.
D) yot embryos still show labelling for c-myc, although reduced; in
both the eye and optic tectum labelling is preserved. Liver also
retains some c-myc labelling. All lateral views are dorsal up, anterior
left.
Figure 6 sfrp2 RNA levels are disturbed in Hh pathway
mutants and after pharmacological treatments. (A, A’’)I nW T
embryos, sfrp2 expression is evident in adaxial cells. This expression
is significantly down-regulated in yot embryos (B, B’’).
Pharmacological treatments with pur and cyc show altered
expression in pharyngeal arches (asterisk in E, compare C, D and E
for different levels of RNA). Anterior is towards left, lateral views are
shown. Full lateral views of embryos are shown in A’ and B’.
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phates. Lack of correlation between changes in indivi-
dual consensus GBS sequences and DNA binding
domains lead us to propose that these motifs might cor-
respond to non-consensus binding sites for Gli1 with
different affinities for the transcription factor. This
hypothesis has been partially addressed in other works.
In [25] for example, mutations of consensus GBS has
been useful to predict potential targets for Gli family in
mammalian enhancers, based in the effect of these
mutations on activation of a luciferase reporter. These
data indicate that variations from consensus GBS can
affect gene expression levels, as also described in [6]. In
[28], an essential binding site from ptc1 promoter, with
a single substitution from the consensus GBS sequence,
was mutated to investigate the effect of change bases in
the expression of a reporter gene, resulting in different
non-consensus and low affinity Gli binding sites that
could lead to transcriptional activation.
Several models have been proposed for Hh activation
of target genes. Gli proteins can bind to regulatory
regions and directly either activate or repress transcrip-
tion. In Drosophila [29] a differential affinity model
seems to represent Hh/Ci signaling in the wing imaginal
disc. It remains to be seen whether Hh signaling in ver-
tebrates follows a similar mechanism. We cannot rule
out a role of Gli repressors (Gli3 in particular) in the
physiological regulation of the new Gli target genes
identified in this paper. The fact that we see increased
expression of ptc1, however, leads us to associate this
regulation preferentially to Gli activator function. It
remains to be defined whether Gli repressor assays yield
the same targets as Gli activators.
A very interesting result of our work is the fact that
we were able to mate yeast zebra fish or mouse Gli con-
structs to either homologous or heterologous libraries.
Indeed, this reveals potential conservation of the inter-
action between the Gli transcription factors and their
putative GBS among vertebrates. Multi-species conser-
vation of the identified sequences was also addressed.
The majority of the assayed genes showed low percen-
tage of mice-rat-human similarity or murine only con-
servation. Some genes like neo1 showed a high
percentage of conservation in mice-rat-human compari-
sons, while others like sfrp2 did not show any conserva-
tion, probably due to the partial presence of repeating
elements. Some of these sequences, though, also show
predicted repeating elements, which might account for
the absence of conservation observed in the multiple
alignments.
Target gene expression
Further experiments using the Hh-responsive cell line
C3H10T1/2 confirmed the results obtained from our
screening, showing positive correlations of expression
level loss to pharmacological loss of function of the Hh/
Gli pathway. Interestingly, though, none of our chosen
genes show an “early response” to cyc treatments, with
reduced mRNA levels coming after 12 hours of treat-
ment like ptc1. Instead they displayed a slower response
to pathway inhibition, where expression is significantly
reduced only after 24 hours of treatment. Similarly, 24
hours pur treatment showed a rather modest increase in
target genes, such as neo1 and c-myc, in comparison to
the well known described ptc1 up-regulation. This may
suggest different levels of regulation, possibly due to the
different genomic and regulatory contexts of the given
promoters causing a different response dynamic than
ptc1. Indeed, it has been reported that the expression of
some Hh target genes depends on pathway activation (e.
g. that of gli1), whereas other targets must be expressed
prior to the induction of Gli activators, which then have
their expression increased via positive feedback (e.g.
ptc1). Thus, it will be interesting to discover possible
similarities and differences in the transcription of differ-
ent types of Hh target genes.
Our results clearly indicate the necessity for function-
ally testing individual genes and associated networks
resulting from bioinformatics analysis. That some of the
selected targets do not show increased mRNA levels
when cells are treated with the pur agonist (like sfrp2)i s
likely due to additional signals regulating gene expres-
sion. Gain-of-function provides extra information on the
mechanisms of Gli-mediated transcription of these tar-
get genes when compared to loss-of-function treat-
ments. The fact that seven out of eight of the chosen
genes show reduced mRNA after cyc treatment high-
lights the degree of accuracy that our screen assay pro-
vides for identifying target genes and corroborates our
selection criteria.
A major finding of this study is the identification of
several novel Shh target genes that we show to be
important for embryonic development in-vivo. The use
of zebrafish embryos as an in-vivo model to validate tar-
get genes has been previously reported [7], and our ISH
provided a spatial-temporal resolution to changes
observed at the transcript level in cell culture. Here we
tested three candidate genes, selected based on their
involvement in different processes during development.
sfrp2 is involved in myoblast differentiation [30]. c-myc
is involved in the cell cycle and critically regulates cell
proliferation [31]. neo1 has been related to axon migra-
tion and more recently to neural progenitor proliferation
in the CNS [32]. The Shh pathway has been classically
implicated in both myogenesis and neurogenesis.
Indeed, Shh loss of function in early development gener-
ates severe alterations in slow muscle development [33].
Patterning of the dorsal/ventral axis, specification of
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tion of dorsal brain structures like the cerebellum, optic
tectum and the neocortex also rely on Shh signaling
[6,18]. In addition to the key functions of Shh in CNS
development, is also implicated in oncogenesis. Shh sig-
naling is deregulated in medulloblastomas (MB),
embryonic tumors composed of primitive-appearing
cells that arise in the cerebellum. Interestingly, a recent
survey of the methylation status of tumor suppressors
or oncogenes in human MBs has revealed among several
epigenetic silencers sfrp family members [34].
All chosen candidate genes evaluated in the zebrafish
embryo showed altered expression consistent with the
in-vitro data obtained from C3H10T1/2. Their response
in-vivo in the zebrafish embryo was a very context
dependent response, with expression showing variation
in some structures while remaining unaltered in others.
Not all expression was ablated in smu mutants, however,
so this might pertain to additional signals that could be
regulating expression in a context-dependent manner in
the zebrafish embryo. All three Gli family members
have been shown to recognize the same GBS and share
redundant functions. However, our data clearly show
functional differences between Gli1 and Gli2 members,
as evidenced by the zebrafish mutant analysis. Thus it is
of great interest to further investigate the specific func-
tions of each Gli transcription factor, sorting out their
distinct and overlapping roles upon targets.
Conclusions
Our study uncovered target genes previously linked to
Shh signaling and, most importantly, previously
unknown genes likely to play important roles during
embryonic development. Several new candidates, includ-
ing positive controls, whose modulation by Shh/Gli has
been reported, were analyzed in the context of zebrafish
development. These findings extend our knowledge of
the Shh regulatory pathway function in development.
Attaining a thorough understanding of Hh signaling is
of vital importance for developing a mechanistic under-
standing of congenital abnormalities and diseases.
Methods
Yeast growth, complementation and colony sequencing
Yeast protocols (growth and mating) were performed as
described in [9]. Plasmids used for yeast libraries are the
same as in [9]. Sequencing was performed as described
in [9].
MEME & MAST analysis
Intronic and upstream regions were obtained either
through the ENSEMBL database or the UCSC genome
browser database. Motif searches were performed using
standalone MEME suite software available at http://
meme.sdsc.edu/meme/cgi-bin/meme.cgi. MEME was
run with the following parameters: -dna -mod tcm
-nmotifs 3 -minw 6 -maxw 14 -evt 1e100 -revcomp
-time 7200 -maxsize 60000 -nostatus -maxiter 20.
MAST was running using -remcorr and -norc
parameters.
Clustal alignment
Sequence from Gli1, Gli2 and Gli3 proteins were
obtained from the ENSEMBL database. Alignment was
performed with the Bioedit editor [9], with default
options for Clustal. For Gene Ontology analysis, we
used DAVID at http://david.abcc.ncifcrf.gov/home.jsp
and AmiGO at http://amigo.geneontology.org/.
C3H10T1/2 cell culture and treatment
The cell line was obtained from ATCC. Cells were
g r o w ni nD u l b e c c o ’s Modified Eagle Media (DMEM)
supplemented with 10% Fetal Bovine Serum (FBS). Cells
were passaged at 80% confluence and passages 2
through 9 were used. Gain and loss of function experi-
ments were performed according to [35] Briefly, consid-
ering that these cells are highly contact inhibited we
performed experiments once the cell projections are
touching, but before full confluence (aprox. 60% conflu-
ence). Cells were not serum deprived before treatments;
cyc was added in presence of 10% FBS, whereas pur was
given in 0.5% FBS. Cells were treated for 24 hrs in pre-
sence of 0.5% FBS with either 1.25 μg/mL of the protein
synthesis inhibitor CHX alone or in combination with
the Hh agonist.
Quantitative real-time PCR (qPCR)
RNA was extracted using TRI Reagent (Ambion)
according to the manufacturer’s recommendations. RNA
integrity and purity were electrophoretically verified by
ethidium bromide staining and by OD260/OD280 nm
absorption ratio. RNAs were then treated with Turbo
DNA-free kit (Ambion) and reverse transcribed with
Oligo-dT and Superscript II (Invitrogen). Transcripts of
Bacillus subtilis dap gene were added to the total RNA
of each sample (1:2,000) as spike-in controls to monitor
the efficiency of reverse transcription. To generate the
spike-in control RNA, the plasmid containing B. subtilis
dap gene was purified from strain ATCC 87486. Linear
template DNA was generated by digesting the plasmid
with restriction enzyme NotI and RNA was produced by
in-vitro transcription using T3 RNA polymerase. The
specific forward and reverse oligonucleotide primers for
target genes and for reference gene (Additional file 4)
were designed using Primer Premier 5.0 software (Pre-
mier Biosoft International), based on GeneBank database
sequences. Quantitative RT-PCR (qPCR) reactions were
performed in a LightCycler system (Roche) using SYBR
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tion reaction contained: 1 μL of LightCyclerTM DNA
Master SYBR
® Green I, 25 mM MgCl2, 10 μMo ff o r -
ward and reverse primers and 100 ng of cDNA in a
total volume of 10 μL. The following standard thermal
profile was used: denaturation at 95°C for 10 min, fol-
lowed by 35 three-step cycles of template denaturation
at 95°C with a 5 s hold, primer annealing at 58-64°C for
10 s and extension at 72°C for 10 s. Data were analyzed
using the LightCycler Software (v3, Roche). The reaction
efficiency was determined for each PCR reaction with
LinRegPCR v7.5 [36]. Three technical replicates were
done for each combination of cDNA and primer pair,
and the quality of the PCR reactions was checked
through analysis of the dissociation and amplification
curves. The products were resolved by 2% agarose gel
electrophoresis to confirm the DNA fragments of
expected size. Transcript levels of target genes within a
cDNA were normalized to the respective transcript level
of gapdh as described in [37]. To test whether gadph
behaves as a housekeeping gene in the analyzed samples,
transcript levels of gadph and dap were measured by
qPCR in each cDNA sample and the ratios of control
transcript to the endogenous transcript gadph were cal-
culated. The results indicated that the abundance of
gadph mRNA remains stable between samples (data not
shown). qPCR reactions were performed on material
from at least two independent biological experiments.
To assess differences among treatments, we applied a
one-way ANOVA and a posteriori LSD Fisher test. A p-
value < 0.05 was considered statistically significant. Data
from the CHX experiment were processed as described
above, except that results were expressed as a ratio of
relative transcript levels between control and treated
cells.
Zebrafish embryos
Wild-type and mutant zebrafish embryos were main-
tained at 28°C as described in the Zebrafish Book [38],
and staged accordingly [39]. Mutant lines used were
smooth-muscle omitted (smuhi1640; [40,41], a loss-of-
function smoothened allele, detour (dtrts269; [41]), a
loss-of-function gli1 allele and you-too (yot; [42]), a
negative dominant allele for gli2. Mutants were main-
tained as heterozygotes and heterozygous adults were
crossed to produce homozygous mutant offspring.
Homozygous mutant individuals were identified by
morphological criteria (dtr and yot). Developmental
time points are expressed as hours post-fertilization
(hpf).
All animal procedures were in accordance with the
Chilean legislation and were approved by Institutional
Animal Care and Use Committees.
RNA in situ hybridization
In situ hybridization was performed essentially as pre-
viously described [43]. Partial neogenin1 (neo1) cDNA
was isolated by PCR and a digoxigenin-labelled anti-
sense neo1 probe was synthesized from the cDNA
clone. The clone was linearized with ApaI and tran-
scribed with T7 polymerase (Roche, Hertfordshire, UK).
c-myc cDNA clone was a kind donation from Dr. Nora
Calcaterra. Plasmid was digested with EcoRI then anti-
sense probe generated using T7 polymerase. sfrp2 clone,
a donation from Dr. Corinne Houart, linearized with
EcoRI and anti-sense probe transcribed using T7
polymerase.
Pharmacological treatments
Zebrafish embryos were treated with 10 μM cyc (Infinity
Pharmaceuticals, Inc., Cambridge, MA) by adding 1 μl
of a 10 mM stock solution (in 95% EtOH) to 1 ml of E3
medium at defined time points. Control embryos were
treated simultaneously with an equal volume (1 μl) of
95% EtOH (cyc carrier). For pur (Calbiochem, CA)
treatments embryos were grown in E3 medium with 10
μM of the Hh agonist at indicated time points and con-
trol embryos were treated with 1% DMSO in E3 med-
ium. Treatments were carried out in 6-well plates in 2
mL E3 medium (30 embryos/well) at 28.5°C. Embryos
were fixed with 4% paraformaldehyde, dehydrated in
MeOH and processed for in situ hybridization and/or
antibody labelling. Effectiveness of cyc was verified by
decreased ptc1 expression of treated embryos while pur
showed to be specific to Hh signaling, as indicated by
increased ptc1 expression (shown in Additional File 5).
Imaging
Photographs were either taken with a Leica DFC 300 FX
camera using a Leica MZ12 dissecting microscope.
Images were processed with Photoshop 7.0 for Macin-
tosh and Image J (NIH).
Additional material
Additional file 1: Table listing all binding sites found in Shh/Gli
yeast assay through our screening strategy. Total mouse GBS positive
sequences mapped to specific genes based on shortest distance to the
transcriptional start sites.
Additional file 2: GBS interspecies conservation. in silico analysis of
GBS found in the promoter of selected vertebrate genes.
Additional file 3: Direct regulation of novel Shh/Gli target genes in
the CH310T1/2 murine cell line. CHX 24 hours treatment confirm
direct regulation for canonical Shh regulated genes.
Additional file 4: Table listing all primers used in this study. Primers
designed for control and novel Shh/Gli target gene quantitative PCR
assays.
Additional file 5: Analysis of in-vivo drug response based on ptc1
expression. Control of zebrafish long-term pharmacological Hedgehog
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verified by in situ hybridization.
Abbreviations
Hh: Hedgehog; Shh: Sonic Hedgehog; TC: Optic tectum; CNS: Central
Nervous System; Ptc1: Patched1; Smo: Smoothened; WT: Wild type; hpf:
hours post fertilization; smu: slow-muscle-omitted; dtr: detour; yot: you too;
cyc: cyclopamine; qPCR: quantitative Real Time PCR.
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